Compounds > 5-(4-acetamidophenyl)pyrazin-2(1h)-one
Page last updated: 2024-09-03

5-(4-acetamidophenyl)pyrazin-2(1h)-one and Coronary Disease

5-(4-acetamidophenyl)pyrazin-2(1h)-one has been researched along with Coronary Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Betton, GR; Isaacs, KR; Joseph, EC1

Other Studies

1 other study(ies) available for 5-(4-acetamidophenyl)pyrazin-2(1h)-one and Coronary Disease

ArticleYear
Coronary vascular lesions in dogs treated with phosphodiesterase III inhibitors.
    Toxicologic pathology, 1989, Volume: 17, Issue:1 Pt 2

    Topics: Aminophylline; Animals; Coronary Disease; Coronary Vessels; Digoxin; Dogs; Electrocardiography; Female; Guanidines; Male; Myocardium; Phosphodiesterase Inhibitors; Pyrazines; Pyridazines; Pyridines

1989